Onset of action of loratadine/montelukast in seasonal allergic rhinitis patients exposed to grass pollen

Arzneimittel-Forschung/Drug Research

Volumn 60, Issue 5, 2010, Pages 249-255

  Horak, Friedrich ^a   Zieglmayer, Petra ^a   Zieglmayer, René ^b   Lemell, Patrick ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Department Vienna Challenge Chamber   (Austria)

Author keywords

Allergic rhinitis; CAS 151767 02 1; CAS 79794 75 5; Loratadine; Montelukast; Nasal congestion; Vienna challenge chamber

Indexed keywords

LORATADINE; LORATIDINE PLUS MONTELUKAST; MONTELUKAST; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG SENSITIVITY; DRUG TOLERABILITY; FEMALE; GRASS POLLEN; HAY FEVER; HUMAN; KNEE FRACTURE; MAJOR CLINICAL STUDY; MALE; NOSE CONGESTION; PHASE 3 CLINICAL TRIAL; RHINOMANOMETRY; SCORING SYSTEM; SINGLE DRUG DOSE; UPPER RESPIRATORY TRACT INFECTION;

EID: 77953205334     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296281     Document Type: Article

References (23)

1. Horak F, Jager S, Nirnberger G, Berger U, Andresen L, Vix JM, Rehn D. Pharmacodynamic dose finding of dimetindene in a sustained release formulation. Arzneimittelforschung. 1993;43(11):1193-1195 (Pubitemid 23350283)
2. Day JH, Ellis AK, Rafeiro E, Ratz JD, Briscoe MP. Experimental models for the evaluation of treatment of allergic rhinitis. Ann Allergy Asthma Immunol. 2006;96:263-277
3. Day JH, Horak F, Briscoe MP, Canonicaz GW, Fineman SM, Krugz N, et al. The role of allergen challenge chambers in the evaluation of anti-allergic medication: an international consensus paper. Clin Exp Allergy Rev. 2006;6:31-59.
4. Krug N, Hohlfeld JM, Larbig M, Buckendahl A, Badorrek P, Geldmacher H, et al. Validation of an environmental exposure unit for controlled human inhalation studies with grass pollen in patients with seasonal allergic rhinitis. Clin Exp Allergy. 2003;33:1667-1674 (Pubitemid 38005386)
5. Horak F, Stubner UP, Zieglmayer R, Harris AG. Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit. J Allergy Clin Immunol. 2002;109:956-961 (Pubitemid 34634305)
6. Horak F, Stubner P, Zieglmeyer R, Harris Ag. Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure. Allergy. 2003;58:481-485 (Pubitemid 36649307)
7. Stuebner P, Horak F, Zieglmayer R, Arnaiz E, Leuratti C, Perez I, et al. Effects of rupatadine vs. placebo on allergen-induced symptoms in patients exposed to aeroallergens in the Vienna challenge chamber. Ann Allergy Asthma Immunol. 2006;96:37-44. (Pubitemid 43152666)
8. Horak F, Jager S, Toth J, Berger U. Efficacy and tolerability of astemizole-D and loratadine-D during prolonged, controlled allergen challenge in the Vienna challenge chamber. Arzneimittelforschung. 1996;46(11):1077-1081
9. Kyrein HJ, Horak F, Nirnberger G, Rehn D. Efficacy of intranasally applied dimethindene maleate solution as spray in adult volunteers with symptoms of seasonal allergic rhinitis in the Vienna challenge chamber. Arzneimittelforschung. 1996;46(8):794-799
10. Horak F, Unkauf M, Beckers C, Mittermaier EM. Efficacy and tolerability of intranasally applied dimetindene maleate solution versus placebo in the treatment of seasonal allergic rhinitis. Arzneimittelforschung. 2000;50(12):1099-1105
11. Shedden A. Impact of nasal congestion on quality of life and work productivity in allergic rhinitis: findings from a large online survey. Treat Respir Med. 2005;4:439-446
12. Allergies in America: A landmark survey of nasal allergy sufferers. Executive summary: available at: http://www.mmcpub.com/scsaia/adultsummary.pdf; accessed January 21, 2009. Florham Park, NJ: Altana Pharma US 2006.
13. Jessen M, Malm L. Definition, Prevalence and development of nasal obstruction. Allergy. 1997;52:3-6.
14. Corey JP, Houser SM, Ng BA. Nasal congestion: a review of its etiology, evaluation, and treatment. Ear Nose Throat J. 2000;79:690-693, 696, 698 passim.
15. Banerji A, Long AA, Camargo CA Jr. Diphenhydramine versus nonsedating antihistamines for acute allergic reactions: a literature review. Allergy Asthma Proc. 2007;28:418-426
16. Bousquet J, Van Cauwenberge P, Bachert C, Canonica GW, Demoly P, Durham SR, et al. Requirements for medications commonly used in the treatment of allergic rhinitis. European academy of allergy and clinical immunology (EAACI), Allergic rhinitis and its impact on asthma (ARIA). Allergy. 2003;58:192-197
17. Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol. 2000;105:917-922 (Pubitemid 30324400)
18. Nayak AS, Philip G, Lu S, Malice MP, Reiss TF. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Ann Allergy Asthma Immunol. 2002;88:592-600.
19. Prenner B, Anolik R, Danzig M, Yao R. Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: effects on nasal congestion. Allergy Asthma Proc. 2009;30(3):263-269
20. Day J, Briscoe M, Ratz J, Danzig M, Yao R. Efficacy of loratadine/montelukast on the symptom of nasal congestion in subjects with seasonal allergic rhinitis in an environmental exposure unit. Ann Allergy Asthma Immunol. 2009;102(4):328-338
21. Day J, Briscoe M, Ratz J, Ellis A, Yao R, Danzig M. Onset of action of loratadine/montelukast in seasonal allergic rhinitis subjects exposed to ragweed pollen in the environmental exposure unit. Allergy Asthma Proc. 2009;30(3):270-276
22. Nathan RA, Eccles R, Howarth Hh, Steinsvag SK, Togias A. Objective monitoring of nasal patency and nasal physiology in rhinitis. J Allergy Clin Immunol. 2005;115:S442-59.
23. Green RJ, Davis G, Price D. Concerns of patients with allergic rhinitis: the allergic rhinitis care programme in South Africa. Prim Care Respir J. 2007;16:299-303. (Pubitemid 47607072)